APLN and hepatocellular carcinoma: Both BYL-719 and GDC-0941 treatment effectively inhibited Akt phosphorylation (Figure S5C), and markedly abolished growth promoting effect of APLN (Figure 5B), indicating that APLN promotes HCC by activating PI3K/Akt pathway.